,Group,Gilenya_pat,Gilenya_relapse,Gilenya_relapse_rate,Tecfidera_pat,Tecfidera_relapse,Tecfidera_relapse_rate,actual_treatment,expect_Gilenya_relapse_rate,expect_Tecfidera_relapse_rate,expect_treatment
training,lowest 35%,615,69,0.11219512195122,314,64,0.203821656050955,-0.0916265340997359,0.10847242433935,0.216214527141151,-0.1077421028018
training,middle 30%,496,35,0.0705645161290323,301,25,0.0830564784053156,-0.0124919622762834,0.0688110721035068,0.0909542319396461,-0.0221431598361394
training,highest 35%,618,99,0.160194174757282,311,37,0.118971061093248,0.041223113664034,0.16211021593891,0.109517918432319,0.0525922975065903
test,lowest 50%,200,24,0.12,132,16,0.121212121212121,-0.00121212121212122,0.0977712062032313,0.182933481254614,-0.0851622750513824
test,highest 50%,220,28,0.127272727272727,111,14,0.126126126126126,0.00114660114660114,0.147769608241258,0.109495458188518,0.0382741500527407
